References:

1. Udager AM. Top 10 Significant Spindled head and neck lesions to scrutinize. Head Neck Pathol. 2023;17(1):132-142. doi:10.1007/s12105-023-01535-z
2. Wakely PE, Saoud C, Ali SZ. Synovial sarcoma: cytopathology of 51 cases highlighting the application of ancillary molecular testing. J Am Soc Cytopathol. 2023;12(4):284-295. doi:10.1016/j.jasc.2023.04.003
3. Gazendam AM, Popovic S, Munir S, Parasu N, Wilson D, Ghert M. Synovial sarcoma: a clinical review. Curr Oncol. 2021;28(3):1909-1920. doi:10.3390/curroncol28030177
4. Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am J Surg Pathol. 2002;26(11):1434-1440. doi:10.1097/00000478-200211000-00005
5. Zaborowski M, Vargas AC, Pulvers J, et al. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases. Histopathology. 2020;77(4):588-600. doi:10.1111/his.14190
6. Baranov E, McBride MJ, Bellizzi AM, et al. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma. Am J Surg Pathol. 2020;44(7):922-933. doi:10.1097/PAS.0000000000001447